---
$id: https://graph.org.ai/products/commodity/51111624
$type: Product
source: UNSPSC
code: "51111624"
title: "Ancitabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ancitabine

**UNSPSC Code**: 51111624
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C9H11N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DO2D32W0VC, chemically known as 2,2-o-cyclocytidine but generally known as ancitabine, which bears US NIH Compound Identifier 25051. Ancitabine most often comes in base and hydrochloride forms. European Medicines Agency schedules Ancitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05507MIG. The term ANCITABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). ANCITABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ancitabine under HS 29349990 and SITC 51579. As of Q4 2014, ANCITABINE remains the US FDA Preferred Term for this commodity. Ancitabine bears US NLM identifiers UMLS ID CL406826 and NCI Concept Code C80636. SMILES: O1C2N3C(OC2C(O)C1CO)NC(=N)CC3.

